Oncology Clinical Trials Market Size, Share & Industry Analysis, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Type (Breast Cancer, Melanoma, Colorectal Cancer, Prostate Cancer, Lung Cancer, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113466

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Oncology Clinical Trials - by Key Countries, 2024
2. Distribution of Oncology Clinical Trials
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of the Europe
Asia Pacific Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. IQVIA Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Parexel International Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Medpace
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. ICON plc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Charles River Laboratories
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Fortrea
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Syneos Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Number of Oncology Clinical Trials - by Key Countries, 2024
2. Distribution of Oncology Clinical Trials
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of the Europe
Asia Pacific Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
3. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World Oncology Clinical Trials Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Phase
  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
2. Market Analysis, Insights and Forecast – By Types
  1. Breast Cancer
  2. Melanoma
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Lung Cancer
  6. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. IQVIA Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Parexel International Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Medpace
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. ICON plc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Charles River Laboratories
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Fortrea
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Syneos Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Oncology Clinical Trials Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Oncology Clinical Trials Market Value Share (%), by Phase, 2024 & 2032

Figure 3: Global Oncology Clinical Trials Market Value Share (%), by Application, 2024 & 2032

Figure 4: Global Oncology Clinical Trials Market Value (USD billion), by Region, 2024 & 2032

Figure 5: North America Oncology Clinical Trials Market Value (USD billion), by Phase, 2024 & 2032

Figure 6: North America Oncology Clinical Trials Market Value Share (%), by Phase, 2024

Figure 7: North America Oncology Clinical Trials Market Value (USD billion), by Application, 2024 & 2032

Figure 8: North America Oncology Clinical Trials Market Value Share (%), by Application, 2024

Figure 9: North America Oncology Clinical Trials Market Value (USD billion), By Country, 2024 & 2032

Figure 10: North America Oncology Clinical Trials Market Value Share (%), By Country, 2024

Figure 11: Europe Oncology Clinical Trials Market Value (USD billion), by Phase, 2024 & 2032

Figure 12: Europe Oncology Clinical Trials Market Value Share (%), by Phase, 2024

Figure 13: Europe Oncology Clinical Trials Market Value (USD billion), by Application, 2024 & 2032

Figure 14: Europe Oncology Clinical Trials Market Value Share (%), by Application, 2024

Figure 15: Europe Oncology Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 16: Europe Oncology Clinical Trials Market Value Share (%), By Country/ Sub-region, 2024

Figure 17: Asia Pacific Oncology Clinical Trials Market Value (USD billion), by Phase, 2024 & 2032

Figure 18: Asia Pacific Oncology Clinical Trials Market Value Share (%), by Phase, 2024

Figure 19: Asia Pacific Oncology Clinical Trials Market Value (USD billion), by Application, 2024 & 2032

Figure 20: Asia Pacific Oncology Clinical Trials Market Value Share (%), by Application, 2024

Figure 21: Asia Pacific Oncology Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 22: Asia Pacific Oncology Clinical Trials Market Value Share (%), By Country/ Sub-region, 2024

Figure 23: Rest of the World Oncology Clinical Trials Market Value (USD billion), by Phase, 2024 & 2032

Figure 24: Rest of the World Oncology Clinical Trials Market Value Share (%), by Phase, 2024

Figure 25: Rest of the World Oncology Clinical Trials Market Value (USD billion), by Application, 2024 & 2032

Figure 26: Rest of the World Oncology Clinical Trials Market Value Share (%), by Application, 2024

Figure 27: Global Oncology Clinical Trials Market Share (%), By Company, 2024

List of Tables

Table 1: Global Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2019–2032

Table 2: Global Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 3: Global Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Region, 2019–2032

Table 4: North America Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2019–2032

Table 5: North America Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 6: North America Oncology Clinical Trials Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 7: Europe Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2019–2032

Table 8: Europe Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 9: Europe Oncology Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019–2032

Table 10: Asia Pacific Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2019–2032

Table 11: Asia Pacific Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 12: Asia Pacific Oncology Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019–2032

Table 13: Rest of the World Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Phase, 2019–2032

Table 14: Rest of the World Oncology Clinical Trials Market Revenue (USD billion) Forecast, by Application, 2019–2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 130

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com